Home LiteratureArticle Details
PMID: 94202 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Synthesis of substance P analogs and agonistic and antagonistic activities.

Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry ·Vol. 33 ·No. 9 ·1979-00-00 ·Pages 664-8

Leban J, Rackur G, Yamaguchi I, Folkers K, Björkroth U, Rosell S, Yanaihara N, Yanaihara C

Abstract

Fourteen analogs of substances P (SP), six previously synthesized by a solution method and eight newly synthesized by a solid-phase technique, have been tested for agonistic and antagonistic activities utilizing the isolated guinea pig ileum. The primary objective is to achieve effective inhibitors of SP. These analogs had agonistic activities ranging from negligible to that equivalent to SP. Six of the fourteen analogs had some degree of antagonistic activity [D-Leu8, D-Phe9]-SP is an analog which constitutes a lead to new substitutions, because it had antagonistic activity, but only negligible agonistic activity. One concept for effective antagonistic activity requires negligible or no agonistic activity.

MeSH Terms
Animals Biological Assay Guinea Pigs Ileum/drug effects Methods Muscle Contraction/drug effects Structure-Activity Relationship Substance P/analogs & derivatives,chemical synthesis,pharmacology
Chemicals
Substance P
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Leban J
Rackur G
Yamaguchi I
Folkers K
Björkroth U
Rosell S
Yanaihara N
Yanaihara C
Article Info
Journal
Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry
Abbr.
Acta Chem Scand B
ISSN
0302-4369
Published
1979-00-00
Pages
664-8
Language
English
Region
Denmark
NLM ID
0421265
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com